Interventional Cardiology News and Research

RSS

MITHRAS trial investigates superiority of TMVR-induced iASD over medical therapy

The MITHRAS randomized clinical trial found that interventional closure of an iatrogenic atrial septal defect (iASD) driven by transcatheter mitral valve repair (TMVR) was not superior to conservative medical treatment with regard to the primary endpoint of change in six-minute walking distance.

16 Oct 2020

REFLECT II clinical trial evaluates safety and efficacy of cerebral embolic deflection filter

The REFLECT II randomized clinical trial evaluating the safety and efficacy of a device designed to reduce cerebral embolization and ischemic stroke, complications of transcatheter aortic valve replacement (TAVR), found that the device met the primary safety endpoint compared to historical controls but did not demonstrate superiority of the device for the primary hierarchical efficacy endpoint.

16 Oct 2020

New self-expanding bioprosthetic valve used in TAVR fails to demonstrate non-inferiority

In a randomized clinical trial, SCOPE II, a new self-expanding bioprosthetic valve used in transcatheter aortic valve replacement (TAVR) failed to demonstrate non-inferiority compared to an existing self-expanding valve.

16 Oct 2020

Rush receives highest honor for nursing excellence for the fifth time

For the fifth consecutive time, Rush University Medical Center has received Magnet designation, the highest national recognition given for nursing excellence. The designation recognizes Rush's nursing staff for overall excellence and for providing the very best care to patients.

13 Oct 2020

New approach can help paramedics better identify patients at high risk for adverse cardiac events

Is this person with chest pain having a heart attack? That's a question EMTs frequently confront when responding to 911 calls.

7 Oct 2020

Heart cell treatment can benefit patients, shows study

More than three years after a clinical trial was prematurely ended for failing to show progress in healing heart attack scars, a prominent peer-reviewed journal is publishing some surprising results showing that the heart cell treatment does benefit patients.

4 Aug 2020

Researchers initiate multiple studies to identify coronavirus-related heart problems

COVID-19 is shown to impact the heart and, in some cases, have long-lasting cardiac effects. To discover the extent to which COVID-19 affects the heart, cardiologists and researchers with the University of Miami Miller School of Medicine have begun multiple studies.

4 Aug 2020

ESC Congress 2020 to host the biggest online gathering of cardiovascular professionals

The world's largest cardiovascular meeting - ESC Congress 2020 - is set to host the biggest online gathering of cardiovascular professionals the world has ever seen.

22 Jul 2020

SCAI releases statement on performance of PCI in ambulatory surgical centers

The Society for Cardiovascular Angiography and Interventions (SCAI) today issued a position statement on the performance of percutaneous coronary intervention (PCI) in ambulatory surgical centers (ASCs). The document was published in SCAI's official journal, Catheterization and Cardiovascular Interventions.

15 May 2020

Experts propose three areas that must be considered when resuming cardiovascular procedures

The American College of Cardiology together with other North American cardiovascular societies has issued a framework for ethically and safely reintroducing invasive cardiovascular procedures and diagnostic tests after the initial peak of the COVID-19 pandemic.

5 May 2020

A systematic framework to reintroduce cardiovascular diagnosis and treatment care during COVID-19

The American Heart Association, together with 14 cardiovascular societies in North America, today issued joint guidance, "Safe Reintroduction of Cardiovascular Services during the COVID-19 Pandemic: Guidance from North American Society Leadership," to outline a systematic, phased approach to safely reintroducing cardiovascular procedures for diagnosis and treatment during the COVID-19 pandemic.

5 May 2020

SCAI releases position statement on adult congenital cardiac interventional training

The Society for Cardiovascular Angiography and Interventions (SCAI) has released a position statement on adult congenital cardiac interventional training, competencies and organizational recommendations.

16 Apr 2020

Using robotics in neuroendovascular procedures

Surgeons at the Sidney Kimmel Medical College at Thomas Jefferson University are pioneering the use of robotics in neuroendovascular procedures, which are performed via the blood vessels of the neck and brain.

2 Mar 2020

Guideline-directed treatment is as effective as invasive procedures in patients with stable CAD

New study results found that guideline-directed medical treatment is as effective as invasive procedures, such as coronary stenting, at preventing heart attack, stroke, and death in patients with stable coronary artery disease.

4 Feb 2020

First robotic coronary angioplasties with R-One successfully completed in Germany

Robocath, a company that designs, develops and commercializes cardiovascular robotic systems for the treatment of vascular diseases, today announces it has successfully completed its first robotic coronary angioplasties with R-One in Germany.

21 Jan 2020

Excessive physical work can damage the heart, says new study

Doing good hard work or exercising well is a tried-and-tested way to improve heart health – right? Well, not always, says a new study published in the journal Hypertension.

4 Nov 2019

More patients may opt for minimally invasive heart valve procedure

Since August, when the Food and Drug Administration approved a minimally invasive heart valve procedure for an expanded group of patients with aortic stenosis, Raj Makkar, MD, vice president of Cardiovascular Innovation and Intervention at Cedars-Sinai, says many more patients are opting for the procedure known as transcatheter aortic valve replacement.

15 Oct 2019

High-risk surgical patients with severe aortic stenosis can benefit from new TAVR system

The Portico IDE study found that 30-day safety and one-year effectiveness outcomes of a novel self-expanding transcatheter aortic valve replacement (TAVR) system for patients with severe aortic stenosis (AS) at high or extreme-risk for surgery was noninferior to contemporary FDA-approved TAVR systems available in the United States.

30 Sep 2019

Polymer drug-eluting and polymer-free drug-coated stents safe and effective for patients with high bleeding risk

The first randomized trial to compare a durable polymer drug-eluting stent to a polymer-free drug-coated stent in patients at high risk of bleeding and treated with one-month dual antiplatelet therapy (DAPT) found that both are clinically safe and effective.

27 Sep 2019

IDEAL LM study: Biodegradable polymer everolimus-eluting stent safe and effective for patients undergoing PCI

New data from the IDEAL-LM trial found that a biodegradable polymer everolimus-eluting stent (BP-EES) followed by four months of dual antiplatelet therapy (DAPT) was safe and effective compared to a conventional durable polymer everolimus-eluting stent (DP-EES) followed by 12 months of DAPT in patients undergoing PCI for unprotected left main coronary artery (uLMCA) disease.

27 Sep 2019

Interventional Cardiology News and Research

MITHRAS trial investigates superiority of TMVR-induced iASD over medical therapy

REFLECT II clinical trial evaluates safety and efficacy of cerebral embolic deflection filter

New self-expanding bioprosthetic valve used in TAVR fails to demonstrate non-inferiority

Rush receives highest honor for nursing excellence for the fifth time

New approach can help paramedics better identify patients at high risk for adverse cardiac events

Heart cell treatment can benefit patients, shows study

Researchers initiate multiple studies to identify coronavirus-related heart problems

ESC Congress 2020 to host the biggest online gathering of cardiovascular professionals

SCAI releases statement on performance of PCI in ambulatory surgical centers

Experts propose three areas that must be considered when resuming cardiovascular procedures

A systematic framework to reintroduce cardiovascular diagnosis and treatment care during COVID-19

SCAI releases position statement on adult congenital cardiac interventional training

Using robotics in neuroendovascular procedures

Guideline-directed treatment is as effective as invasive procedures in patients with stable CAD

First robotic coronary angioplasties with R-One successfully completed in Germany

Excessive physical work can damage the heart, says new study

More patients may opt for minimally invasive heart valve procedure

High-risk surgical patients with severe aortic stenosis can benefit from new TAVR system

Polymer drug-eluting and polymer-free drug-coated stents safe and effective for patients with high bleeding risk

IDEAL LM study: Biodegradable polymer everolimus-eluting stent safe and effective for patients undergoing PCI

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News